Sanara Medtech Inc reports results for the quarter ended June 30 - Earnings Summary
Sanara Medtech Inc reports results for the quarter ended June 30 - Earnings Summary
Sanara Medtech Inc SMTI.OQ reported a quarterly adjusted loss of 5 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -23 cents. The mean expectation of two analysts for the quarter was for a loss of 2 cents per share. Wall Street expected results to range from -7 cents to 2 cents per share.
Revenue rose 8.9% to $28.14 million from a year ago; analysts expected $28.95 million.
Sanara Medtech Inc's reported EPS for the quarter was a loss of 5 cents.
The company reported a quarterly loss of $452 thousand.
Sanara Medtech Inc shares had risen by 45.2% this quarter and gained 46.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Sanara Medtech Inc is $35.00, about 1.8% above its last closing price of $34.38
This summary was machine generated from LSEG data August 11 at 11:23 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.02 | -0.05 | Missed |
Mar. 31 2026 | -0.13 | 0.05 | Beat |
Dec. 31 2025 | 0.11 | 0.09 | Missed |
Sep. 30 2025 | -0.21 | 0.09 | Beat |